Labforward

smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.

Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of sustainable and food alternatives.

NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and pathogens in food.

Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is dedicated to researching Tumor-Associated Carbohydrate Antigens (TACAs) as a potential new target for cancer therapy. TACAs are expressed specifically in tumors due to abnormal glycosylation, and contribute to processes like metastasis, angiogenesis, and immune suppression. Tacalyx utilizes advanced carbohydrate synthesis technology to create pure TACA structures, which are then used to develop antibodies for innovative cancer treatments.

Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and scalable production.

Mbiomics is a company in the field of biotechnology.

At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their solubility, stability, and absorption. Our OPTISOLV® Technology helps deliver natural actives into food, nutraceuticals, pharmaceuticals, and personal care products — more effectively and efficiently. Our goal is to support brands in creating their next product innovation. Developed in Germany. Produced in Europe.

Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored expression systems for enzymes from picoliter to large-scale fermentation. They are building on their experience in engineering a wide range of industrial organisms including bacteria, yeast, and filamentous fungi. Their customized enzyme solutions are applicable across industries such as circular economy, food, and feed. Picea Biosolutions is headquartered in Offenburg, Baden-Wurttemberg and was founded in 2022.

KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity. The company's mission is to provide cancer patients with not only safe but also inexpensive immunotherapy, as well as to produce immunostimulatory drugs capable of preventing infectious illnesses.

iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.